Literature DB >> 19913641

The heart in rheumatoid arthritis.

Maurizio Turiel1, Simona Sitia, Fabiola Atzeni, Livio Tomasoni, Luigi Gianturco, Matteo Giuffrida, Vito De Gennaro Colonna, Piercarlo Sarzi-Puttini.   

Abstract

Morbidity and mortality rates are higher in rheumatoid arthritis (RA) patients than in the general population. Many studies have shown that coronary artery disease is one of the most common causes of death in RA and seems to occur at a younger age than in the general population. RA per se is as much a cardiovascular (CV) risk factor as diabetes, arterial hypertension and dyslipidemia etc., and so it is necessary to plan a follow-up using the same diagnostic and therapeutic approaches as those commonly used for primary and secondary prevention in non-RA patients at high CV risk. All of the cardiac structures can be affected during the course of RA (valves, the conduction system, the myocardium, endocardium and pericardium, and the coronary arteries), and cardiac complications include a variety of clinical manifestations. As these are all associated with an unfavourable prognosis, it is essential to detect subclinical cardiac involvement in still asymptomatic RA patients in order to assure adequate long-term treatment. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19913641     DOI: 10.1016/j.autrev.2009.11.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  8 in total

Review 1.  The autoimmune side of heart and lung diseases.

Authors:  Nancy Agmon-Levin; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 2.  Cardiac involvement in juvenile idiopathic arthritis.

Authors:  Bulent Koca; Sezgin Sahin; Amra Adrovic; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2016-07-14       Impact factor: 2.631

3.  Pericardial mass in a patient with rheumatoid arthritis.

Authors:  Mohammad Al-Ani; Michelle Weber; David Winchester; Matthew Kosboth
Journal:  BMJ Case Rep       Date:  2015-06-08

4.  Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.

Authors:  Maria Sakkou; Panagiotis Chouvardas; Lydia Ntari; Alejandro Prados; Kristin Moreth; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabe de Angelis; Maria C Denis; Niki Karagianni; George Kollias
Journal:  JCI Insight       Date:  2018-04-05

5.  Cardiovascular involvement in connective tissue disease: the role of interstitial lung disease.

Authors:  XiaoBing Wang; MeiNa Lou; Yongji Li; WenJing Ye; ZhiYong Zhang; Xiufen Jia; HongYing Shi; XiaoChun Zhu; LiangXing Wang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  Non-Bacterial Thrombotic Endocarditis in a Patient with Rheumatoid Arthritis.

Authors:  Jung-Hye Choi; Jeong-Eun Park; Jang-Young Kim; Taeyoung Kang
Journal:  Korean Circ J       Date:  2016-04-28       Impact factor: 3.243

7.  Synovial fluid proteome in rheumatoid arthritis.

Authors:  Mitali Bhattacharjee; Lavanya Balakrishnan; Santosh Renuse; Jayshree Advani; Renu Goel; Gajanan Sathe; T S Keshava Prasad; Bipin Nair; Ramesh Jois; Subramanian Shankar; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2016-06-05       Impact factor: 3.988

8.  Noninvasive imaging methods for evaluating cardiovascular involvement in patients with rheumatoid arthritis before and after anti-TNF drug treatment.

Authors:  Fabiola Atzeni; Luigi Gianturco; Laura Boccassini; Piercarlo Sarzi-Puttini; Gianluca Bonitta; Maurizio Turiel
Journal:  Future Sci OA       Date:  2019-06-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.